W.H. Gerlich

636 total citations
23 papers, 372 citations indexed

About

W.H. Gerlich is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, W.H. Gerlich has authored 23 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 15 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in W.H. Gerlich's work include Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (5 papers). W.H. Gerlich is often cited by papers focused on Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (5 papers). W.H. Gerlich collaborates with scholars based in Germany, Netherlands and France. W.H. Gerlich's co-authors include Hubert G.M. Niesters, R. A. Heijtink, Jurjen Schirm, Wim Quint, D. Blondin, Tobias Heintges, C. Niederau, Dieter Häussinger, Andreas Erhardt and Ortwin Adams and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Hepatology and Journal of General Virology.

In The Last Decade

W.H. Gerlich

19 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W.H. Gerlich Germany	8	314	255	72	46	20	23	372
Hideo Naito Japan	8	434 1.4×	410 1.6×	70 1.0×	11 0.2×	29 1.4×	9	490
Bingfu Jiang Germany	9	221 0.7×	177 0.7×	95 1.3×	77 1.7×	23 1.1×	13	338
Francis K. Mundon United States	7	260 0.8×	187 0.7×	48 0.7×	33 0.7×	6 0.3×	8	312
D.C. Pevear United States	7	227 0.7×	93 0.4×	173 2.4×	96 2.1×	13 0.7×	9	429
Severine Margeridon‐Thermet United States	7	256 0.8×	228 0.9×	107 1.5×	52 1.1×	32 1.6×	8	338
Christine A. Bellezza United States	7	265 0.8×	197 0.8×	80 1.1×	33 0.7×	24 1.2×	7	329
Isabel Maria Vicente Guedes de Carvalho-Mello Brazil	11	284 0.9×	300 1.2×	75 1.0×	31 0.7×	25 1.3×	23	342
E C Ford United States	8	455 1.4×	321 1.3×	151 2.1×	44 1.0×	24 1.2×	9	489
Weiping Qin Japan	5	166 0.5×	227 0.9×	56 0.8×	137 3.0×	46 2.3×	7	341
Peter V. Markov United Kingdom	7	315 1.0×	325 1.3×	49 0.7×	19 0.4×	27 1.4×	10	389

Countries citing papers authored by W.H. Gerlich

Since Specialization

Citations

This map shows the geographic impact of W.H. Gerlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.H. Gerlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.H. Gerlich more than expected).

Fields of papers citing papers by W.H. Gerlich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.H. Gerlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.H. Gerlich. The network helps show where W.H. Gerlich may publish in the future.

Co-authorship network of co-authors of W.H. Gerlich

This figure shows the co-authorship network connecting the top 25 collaborators of W.H. Gerlich. A scholar is included among the top collaborators of W.H. Gerlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.H. Gerlich. W.H. Gerlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomssen, R. & W.H. Gerlich. (2009). Sind Hepatitis-B-Impfstoffe frei von Restinfektiosität?. DMW - Deutsche Medizinische Wochenschrift. 107(33). 1243–1245.

Thomssen, R., W.H. Gerlich, W. Stibbe, et al.. (2008). Herstellung und Erprobung eines Hepatitis-B-Impfstoffes. DMW - Deutsche Medizinische Wochenschrift. 107(4). 125–131. 3 indexed citations

Lutz, Walburga, R. Weiß, Josef Wissing, et al.. (2004). Do Canada geese (Branta canadensis Linnaeus, 1758) carry infectious agents for birds and man?. European Journal of Wildlife Research. 50(2). 16 indexed citations

Gerlich, W.H.. (2004). Hepatitis-Impfung von Blutspendern: notwendig, machbar, bezahlbar?. Transfusion Medicine and Hemotherapy. 31(6). 412–413. 2 indexed citations

Lutz, Walburga, Josef Wissing, W.H. Gerlich, et al.. (2003). Untersuchungen zum Gesundheitsstatus von Kanadagänsen (Branta canadensis, Linnaeus, 1758) in Nordrhein-Westfalen an Hand der Analyse von Eiern. European Journal of Wildlife Research. 49(1). 61–76. 3 indexed citations

Erhardt, Andreas, D. Blondin, W.H. Gerlich, et al.. (2000). Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Journal of Hepatology. 32. 36–36. 111 indexed citations

Caspari, G. & W.H. Gerlich. (2000). Virus Safety of Blood and Plasma Products in Germany – State of Knowledge and Open Problems. Transfusion Medicine and Hemotherapy. 27(6). 286–295. 1 indexed citations

Caspari, G., et al.. (1999). Effekt von Vorspendenergebnissen und vertraulichem Selbstausschluß auf Prävalenz und Inzidenz von HCV bei Blutspendern des DRK-Blutspendedienstes Nordrhein-Westfalen. Transfusion Medicine and Hemotherapy. 26(5). 293–299. 1 indexed citations

Schaefer, Stephan, et al.. (1998). Properties of tumour suppressor p53 in murine hepatocyte lines transformed by hepatitis B virus X protein.. Journal of General Virology. 79(4). 767–777. 21 indexed citations

10.

Vierling, John M., et al.. (1997). The First Flaviviridae Symposium. Intervirology. 40(4). 279–288. 5 indexed citations

11.

Caspari, G., et al.. (1997). Non-specific and specific anti-HCV results correlated to age, sex, transaminase, rhesus blood group and follow-up in blood donors. Archives of Virology. 142(3). 473–489. 8 indexed citations

12.

Damen, M., H.T.M. Cuypers, Hans L. Zaaijer, et al.. (1996). International collaborative study on the second EUROHEP HCV-RNA reference panel. Journal of Virological Methods. 58(1-2). 175–185. 92 indexed citations

13.

Caspari, G., et al.. (1995). Age, Sex and Transaminase Dependency of Specific and Nonspecific Results from Enzyme Immunoassays for Antibodies to Hepatitis C Virus and Follow-Up of Blood Donors. Transfusion Medicine and Hemotherapy. 22(4). 208–219. 7 indexed citations

14.

Quint, Wim, R. A. Heijtink, Jurjen Schirm, W.H. Gerlich, & Hubert G.M. Niesters. (1995). Reliability of methods for hepatitis B virus DNA detection. Journal of Clinical Microbiology. 33(1). 225–228. 73 indexed citations

15.

Gerlich, W.H.. (1992). [Professional activity of HBsAG-positive surgeon].. PubMed. 117(9). 359–359. 3 indexed citations

16.

Gerlich, W.H.. (1991). Hepatitis B surface proteins. Journal of Hepatology. 13. S90–S92. 7 indexed citations

17.

Pontisso, Patrizia, Mariagrazia Ruvoletto, L. Chemello, et al.. (1990). Hepatitis B virus binds to IgA receptors of liver cells. Journal of Hepatology. 11. S50–S50. 1 indexed citations

18.

Gerlich, W.H., K.‐H. Heermann, & R. Thomssen. (1988). [Approaches to developing an optimal vaccine against hepatitis B viruses].. PubMed. 16(5). 167–74. 1 indexed citations

19.

Thomssen, R., W.H. Gerlich, Robin Biswas, et al.. (1976). [Etiology of hepatitis B. Preliminary results of a cooperative study (proceedings)].. PubMed. 235(1-3). 242–52. 1 indexed citations

20.

Gerlich, W.H., et al.. (1975). Separation of morphological types of hepatitis B antigen.. 232. 189–198. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact